UBONG UDOFIA: Open Payments
NPI 1760745889 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$95,473 in 363 payments from 19 companies in 2025. Trend: 2023 $69,134 · 2024 $99,863 · 2025 $95,473
Speaker / faculty: $71,892Food & beverage: $7,268Consulting: $6,000Travel & lodging: $5,952Honoraria: $4,250Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 104 | $60,383 |
| Teva Pharmaceuticals USA, Inc. | 66 | $19,651 |
| ABBVIE INC. | 49 | $7,131 |
| Axsome Therapeutics, Inc. | 23 | $5,710 |
| E.R. Squibb & Sons, L.L.C. | 24 | $491 |
| Alkermes, Inc. | 17 | $480 |
| Vanda Pharmaceuticals Inc. | 10 | $320 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $278 |
| Supernus Pharmaceuticals, Inc. | 15 | $268 |
| Otsuka America Pharmaceutical, Inc. | 13 | $203 |
Products named: INGREZZA, UZEDY, VRAYLAR, Auvelity, COBENFY, AUSTEDO XR, FANAPT, ARISTADA.
Industry payments across NJ — which companies pay providers there.
